Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab

Background/Aims: Rituximab and glucocorticoids are a non-inferior alternative to cyclophosphamide and glucocorticoid therapy for induction of remission in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) patients with moderate renal disease. The efficacy and safety of this appr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of nephrology 2015-01, Vol.41 (4-5), p.296-301
Hauptverfasser:	Shah, Shivani, Hruskova, Zdenka, Segelmark, Marten, Morgan, Matthew D., Hogan, Jonathan, Lee, Steven K., Dale, Jessica, Harper, Lorraine, Tesar, Vladimir, Jayne, David R.W., Geetha, Duvuru
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy Antibodies, Antineutrophil Cytoplasmic - immunology Autoantibodies Care and treatment Cohort Studies Disease Progression Drug Therapy, Combination Female Glucocorticoids - therapeutic use Granulomatosis with Polyangiitis - immunology Granulomatosis with Polyangiitis - therapy Health aspects Humans Immunologic Factors - therapeutic use Kidney diseases Kidney Failure, Chronic Male Microscopic Polyangiitis - immunology Microscopic Polyangiitis - therapy Middle Aged Myeloblastin - immunology Original Report: Patient-Oriented, Translational Research Peroxidase - immunology Physiological aspects Plasmapheresis Remission Induction Renal Insufficiency, Chronic - immunology Renal Insufficiency, Chronic - therapy Retrospective Studies Rituximab Rituximab - therapeutic use Severity of Illness Index Testing Treatment Outcome Vasculitis Vasculitis - immunology Vasculitis - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!